Threshold Pharmaceuticals

Mirum Pharmaceuticals, Inc, based in Foster City, CA, is a company dedicated to developing rare markable medicines to address unmet needs in healthcare. The name "Mirum" itself, derived from Latin, signifies remarkable and extraordinary, reflecting the company's mission to bring hope and joy to those affected by rare diseases. At Mirum, the focus is on creating transformative scientific discoveries that have the potential to change lives. The company's commitment to patients and their families is evident in their drive to turn possibilities into realities, offering a unique opportunity to revitalize communities impacted by rare diseases. Patients and families living with rare diseases are at the heart of Mirum's work. Through their dedication to developing therapies based on meaningful evidence, Mirum Pharmaceuticals aims to bring about breakthrough moments that allow patients to live fully and with hope. Generated from the website content

CG Pharmaceuticals Inc., established in November 2006, is a wholly-owned U.S. subsidiary of CrystalGenomics based in Seoul, Korea. The company is located in Orinda, California, and focuses its efforts on clinical research and development exclusively for its parent company, CrystalGenomics. With a commitment to advancing pharmaceutical innovation, CG Pharmaceuticals serves as a crucial link in the research and development pipeline. Their operations are centered around supporting the initiatives of CrystalGenomics, contributing to the advancement of medical science. Generated from the website

Jazz Pharmaceuticals is a global biopharmaceutical company focused on developing innovative medicines for patients with limited or no treatment options, particularly in the fields of oncology and sleep disorders. The company is committed to transforming lives and redefining possibilities through its pioneering research and development efforts. With a strong emphasis on scientific advancement and corporate responsibility, Jazz Pharmaceuticals aims to bring meaningful innovations to patients facing challenging health conditions. Their dedication is evident in their ongoing partnerships and research initiatives that seek to enhance patient outcomes and overall quality of life. Generated from the website